Relationship between time of day and periprocedural myocardial infarction after elective angioplasty

References

• Blankenship JC, Haldis T, Feit F, et al. (2006). Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy). Am J Cardiol. 97:1591–6
   PubMedGoogle Scholar
• Cai Q, Skelding KA, Armstrong AT Jr, et al. (2007). Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention. Am J Cardiol. 99:616–20
   PubMed Web of Science ®Google Scholar
• Cantor WJ, Strauss BH, Graham MM, et al. (2010). Time of day and outcomes of nonurgent percutaneous coronary intervention performed during working hours. Am Heart J. 159:1133–8
   PubMedGoogle Scholar
• Cuisset T, Hamilos M, Sarma J, et al. (2008). Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. Am J Cardiol. 101:1700–3
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, et al. (2010). Melatonin and circadian biology in human cardiovascular disease. J Pineal Res. 49:14–22
   PubMed Web of Science ®Google Scholar
• Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, et al. (2010). Short communication: Ischemia/reperfusion tolerance is time-of-day-dependent: Mediation by the cardiomyocyte circadian clock. Circ Res. 106:546–50
   PubMed Web of Science ®Google Scholar
• Durgan DJ, Young ME. (2010). The cardiomyocyte circadian clock: Emerging roles in health and disease. Circ Res 106:647–58
   PubMed Web of Science ®Google Scholar
• Ellis SG, Chew D, Chan A, et al. (2002). Death following creatine kinase-MB elevation after coronary intervention: Identification of an early risk period: Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation. 106:1205–10
   PubMed Web of Science ®Google Scholar
• Fournier S, Eeckhout E, Mangiacapra F, et al. (2012). Circadian variations of ischemic burden among patients with myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J. 163:208–13
   PubMed Web of Science ®Google Scholar
• Herrmann J. (2005). Peri-procedural myocardial injury: 2005 update. Eur Heart J. 26:2493–519
   PubMed Web of Science ®Google Scholar
• Herrmann J, Lerman A, Baumgart D, et al. (2002). Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation. 106:2180–3
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Aguirre FV, Aplin R, et al. (2010). Circadian rhythms in patients with ST-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 3:382–9
   PubMed Web of Science ®Google Scholar
• Mandadi VR, DeVoe MC, Ambrose JA, et al. (2004). Predictors of troponin elevation after percutaneous coronary intervention. Am J Cardiol. 93:747–50
   PubMed Web of Science ®Google Scholar
• Nygren J. (2006). The metabolic effects of fasting and surgery. Best Pract Res Clin Anaesthesiol. 20:429–38
   PubMedGoogle Scholar
• Patti G, Colonna G, Pasceri V, et al. (2005). Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 111:2099–106
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29
   PubMed Web of Science ®Google Scholar
• Porto I, Selvanayagam JB, Van Gaal WJ, et al. (2006). Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: Insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 114:662–9
   PubMed Web of Science ®Google Scholar
• Prasad A, Herrmann J. (2011). Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 364:453–64
   PubMed Web of Science ®Google Scholar
• Prasad A, Rihal CS, Lennon RJ, et al. (2008). Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: An analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv. 1:10–19
   PubMed Web of Science ®Google Scholar
• Reiter R, Swingen C, Moore L, et al. (2012). Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ Res. 110:105–10
   PubMed Web of Science ®Google Scholar
• Suarez-Barrientos A, Lopez-Romero P, Vivas D, et al. (2011). Circadian variations of infarct size in acute myocardial infarction. Heart 97:970–6
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. (2012). Third universal definition of myocardial infarction. Circulation 126:2020--35
   Google Scholar
• Thygesen K, Alpert JS, White HD, et al. (2007). Universal definition of myocardial infarction. Circulation. 116:2634–53
   PubMed Web of Science ®Google Scholar
• van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. (2009). The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol. 135:60–5
   PubMed Web of Science ®Google Scholar
• Veselka J, Zemanek D, Hajek P, et al. (2011). Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention. Am J Cardiol. 107:1295–9
   PubMedGoogle Scholar
• Virag JA, Dries JL, Easton PR, et al. (2010). Attenuation of myocardial injury in mice with functional deletion of the circadian rhythm gene mPer2. Am J Physiol Heart Circ Physiol. 298:H1088–95
   PubMed Web of Science ®Google Scholar